Alendronate for Osteonecrosis in Adults With Sickle Cell Disease

Abroad (travel likely)RecruitingPHASE2

Conditions

Sickle Cell Disease · Sickle Cell Anemia · Osteonecrosis · Ischemic Necrosis · Avascular Necrosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

UC Davis Comprehensive Cancer Center, Sacramento, California, United States
Contact: Study coordinator (Leyla Y Teos, PhD) · lyteos@ucdavis.edu · 916-460-2749
Contact: Study coordinator (Oyebimpe O Adesina, MD, MS) · adesina@ucdavis.edu · (916) 703-5166
Contact: Principal Investigator (Oyebimpe O Adesina, MD, MS)

Study leads

Oyebimpe O Adesina, MD, MS
Principal Investigator
UC Davis School of Medicine

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Optimizing Hydroxyurea Therapy in Children With Sickle Cell Anemia In Malaria Endemic Areas: The NOHARM Maximum Tolerated Dose (MTD) Study

Sickle Cell Disease · Sickle Cell Anemia in Children

Abroad (travel likely)RecruitingPHASE1, PHASE2

Kampala, Uganda

Tocilizumab for Acute Chest Syndrome

Sickle Cell Disease · Acute Chest Syndrome

Abroad (travel likely)RecruitingPHASE2

Chicago, United States

T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias

Sickle Cell Anemia · Beta-thalassemia Major · Diamond-blackfan Anemia

Abroad (travel likely)RecruitingPHASE1, PHASE2

Pittsburgh, United States

A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)

Sickle Cell Disease · Thalassemia, Beta · Thalassemia

Abroad (travel likely)RecruitingPHASE2

Basking Ridge, United States · Middletown, United States